Profil
Faiez Zannad is the founder of CardioRenal and holds the title of Director since its founding in 2012.
Dr. Zannad is also the founder of G3 Pharmaceuticals, Inc.
Aktive Positionen von Faiez Zannad
| Unternehmen | Position | Beginn |
|---|---|---|
CardioRenal
 CardioRenal Pharmaceuticals: MajorHealth Technology CardioRenal develops a telemedicine solution for homebound patients with severe heart conditions. It specializes in artificial intelligence and digital health. The firm allows for daily measurements of cardiac biomarkers in a droplet of blood drawn and analyzed by the patients themselves. The company was founded by Faiez Zannad and Patrick Rossignol and is headquartered in Strasbourg, France. | Gründer | 29.10.2012 |
Ehemalige bekannte Positionen von Faiez Zannad
| Unternehmen | Position | Ende |
|---|---|---|
G3 Pharmaceuticals, Inc.
 G3 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology G3 Pharmaceuticals, Inc. is a development-stage biopharmaceutical company. It manufactures and develops galectin-3 biology, cardiovascular pharmaceutical and carbohydrate drugs. The company is headquartered in Lexington, MA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
CardioRenal
CardioRenal Pharmaceuticals: MajorHealth Technology CardioRenal develops a telemedicine solution for homebound patients with severe heart conditions. It specializes in artificial intelligence and digital health. The firm allows for daily measurements of cardiac biomarkers in a droplet of blood drawn and analyzed by the patients themselves. The company was founded by Faiez Zannad and Patrick Rossignol and is headquartered in Strasbourg, France. | Health Technology |
G3 Pharmaceuticals, Inc.
G3 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology G3 Pharmaceuticals, Inc. is a development-stage biopharmaceutical company. It manufactures and develops galectin-3 biology, cardiovascular pharmaceutical and carbohydrate drugs. The company is headquartered in Lexington, MA. | Health Technology |
